Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.

Respiratory medicine - 1 Jan 2015

Brodie Seth A, Li Ge, Brandes Johann C

Abstract excerpt

BACKGROUND: CHFR expression has previously been established as a powerful predictor for response to taxane based first-line chemotherapy in non-small cell lung cancer. It is currently unknown however, if reduced CHFR expression correlates with certain molecular subtypes of lung cancer. PURPOSE: In order to determine which patients may benefit from CHFR biomarker testing we conducted the present study to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Cell Cycle Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Genomic Library

Share to Neoplasm Proteins

Share to Poly-ADP-Ribose Binding Proteins

Share to Sex Factors

Share to Ubiquitin-Protein Ligases

Source

Open in PubMed Open full text

Identifiers

PMID: 25477232
DOI: 10.1016/j.rmed.2014.11.004
PMCID: PMC4277914

Genes

CHFR
EGFR
STK11
ALK
ERBB2
FGFR1
FGFR2
FGFR3
KRAS
MET
RET
ROS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characteristics of non-small cell lung cancer with reduced CHFR expression in The Cancer Genome Atlas (TCGA) project.PMID 25477232Read ↗

Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patientsSemantic proximity Read ↗

Role of FGF Receptors as an Emerging Therapeutic Target in Lung Squamous Cell CarcinomaSemantic proximity Read ↗

CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer.Semantic proximity Read ↗

“Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”Semantic proximity Read ↗

RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer.Semantic proximity Read ↗

Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer.Semantic proximity Read ↗

Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States.Semantic proximity Read ↗

CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes.Semantic proximity Read ↗

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing.Semantic proximity Read ↗

An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.Semantic proximity Read ↗

First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.Semantic proximity Read ↗

Frequency of expression and prognostic implications of emerging molecular targets in pulmonary squamous cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.